Literature DB >> 32042760

Cholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparities.

Hualian Hang1, Seogsong Jeong1, Meng Sha1, Defu Kong1, Zhifeng Xi1, Ying Tong1, Qiang Xia1.   

Abstract

BACKGROUND: Anatomical location is considered in diagnostic and therapeutic approaches of cholangiocarcinoma (CCA). However, disparities and its extents in proportion of surgical candidates, prognostic factors, prognostic genetic networks, susceptibility for lymph node dissection, and disease stage at diagnosis remain to be confirmed.
METHODS: A total of 11,710 patients with cholangiocarcinoma from Surveillance, Epidemiology, and End Results Cancer Registries (SEER) and 45 CCA patients with paired tumor and normal specimens from The Cancer Genome Atlas were studied. Kaplan-Meier estimation, Cox proportional hazards regression, Pearson's correlation, comparison between anatomical location (distal, intrahepatic, and perihilar)-dependent CCAs, differential expressive gene stratification, potential interactive gene identification, and confirmation on pathways of the prognostic networks were carried out.
RESULTS: Survival outcomes were most favorable in the distal type, followed by perihilar and intrahepatic types, but postsurgical prognosis was slightly higher in intrahepatic type compared to perihilar type. Distant historic stage at diagnosis was noticed in intrahepatic type. Significant prognostic factors and their hazards ratios were dependent to the anatomical location. In addition, lymph node dissection provided significant survival benefits in perihilar type only. Furthermore, prognosis-predictive genes, as well as potential processes and pathways, were significantly among the anatomical location-dependent types that the genes barely overlapped.
CONCLUSIONS: There are disparities in almost all aspects among distal, intrahepatic, and perihilar CCAs. Anatomical location needs to be considered in treatment, prognostic estimation, identifying targets, and developing therapeutic approaches for CCA. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Biliary malignancy; bile duct cancer; distal cholangiocarcinoma (dCCA); intrahepatic cholangiocarcinoma (iCCA); perihilar cholangiocarcinoma (hiCCA)

Year:  2019        PMID: 32042760      PMCID: PMC6989985          DOI: 10.21037/atm.2019.12.37

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  26 in total

Review 1.  Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors.

Authors:  Yanming Zhou; Shuncui Liu; Lupeng Wu; Tao Wan
Journal:  Asian J Surg       Date:  2015-08-31       Impact factor: 2.767

2.  Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.

Authors:  Mina Komuta; Bart Spee; Sara Vander Borght; Rita De Vos; Chris Verslype; Raymond Aerts; Hirohisa Yano; Tetsuya Suzuki; Masanori Matsuda; Hideki Fujii; Valeer J Desmet; Masamichi Kojiro; Tania Roskams
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

Review 3.  Intrahepatic cholangiocarcinoma surgery: the impact of lymphadenectomy.

Authors:  Javier C Lendoire; Luis Gil; Oscar Imventarza
Journal:  Chin Clin Oncol       Date:  2018-07-17

Review 4.  New Horizons for Precision Medicine in Biliary Tract Cancers.

Authors:  Juan W Valle; Angela Lamarca; Lipika Goyal; Jorge Barriuso; Andrew X Zhu
Journal:  Cancer Discov       Date:  2017-08-17       Impact factor: 39.397

Review 5.  Current Practice of Hepatocellular Carcinoma Surveillance.

Authors:  Imelda Maria Loho; Lianda Siregar; Agus Sudiro Waspodo; Irsan Hasan
Journal:  Acta Med Indones       Date:  2018-10

6.  Pathological classification of intrahepatic cholangiocarcinoma based on a new concept.

Authors:  Yasuni Nakanuma; Yasunori Sato; Kenichi Harada; Motoko Sasaki; Jing Xu; Hiroko Ikeda
Journal:  World J Hepatol       Date:  2010-12-27

7.  70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

Authors:  Fatima Cardoso; Laura J van't Veer; Jan Bogaerts; Leen Slaets; Giuseppe Viale; Suzette Delaloge; Jean-Yves Pierga; Etienne Brain; Sylvain Causeret; Mauro DeLorenzi; Annuska M Glas; Vassilis Golfinopoulos; Theodora Goulioti; Susan Knox; Erika Matos; Bart Meulemans; Peter A Neijenhuis; Ulrike Nitz; Rodolfo Passalacqua; Peter Ravdin; Isabel T Rubio; Mahasti Saghatchian; Tineke J Smilde; Christos Sotiriou; Lisette Stork; Carolyn Straehle; Geraldine Thomas; Alastair M Thompson; Jacobus M van der Hoeven; Peter Vuylsteke; René Bernards; Konstantinos Tryfonidis; Emiel Rutgers; Martine Piccart
Journal:  N Engl J Med       Date:  2016-08-25       Impact factor: 91.245

Review 8.  Epigenetic aberrations in cholangiocarcinoma: potential biomarkers and promising target for novel therapeutic strategies.

Authors:  Temduang Limpaiboon
Journal:  Asian Pac J Cancer Prev       Date:  2012

Review 9.  Molecular Pathogenesis of Cholangiocarcinoma.

Authors:  Peter L Labib; George Goodchild; Stephen P Pereira
Journal:  BMC Cancer       Date:  2019-02-28       Impact factor: 4.430

Review 10.  Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis.

Authors:  Nicha Wongjarupong; Buravej Assavapongpaiboon; Paweena Susantitaphong; Wisit Cheungpasitporn; Sombat Treeprasertsuk; Rungsun Rerknimitr; Roongruedee Chaiteerakij
Journal:  BMC Gastroenterol       Date:  2017-12-08       Impact factor: 3.067

View more
  4 in total

1.  Cholangiocarcinoma: three different entities based on location.

Authors:  Christopher T Aquina; Timothy M Pawlik; Aslam Ejaz
Journal:  Ann Transl Med       Date:  2020-06

2.  Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study.

Authors:  Peng Liao; Li Cao; Hang Chen; Shui-Zi Pang
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

3.  Differentiation combined hepatocellular and cholangiocarcinoma from intrahepatic cholangiocarcinoma based on radiomics machine learning.

Authors:  Jun Zhang; Zixing Huang; Likun Cao; Zhen Zhang; Yi Wei; Xin Zhang; Bin Song
Journal:  Ann Transl Med       Date:  2020-02

Review 4.  Systemic treatment options for advanced biliary tract carcinoma.

Authors:  Changqing Xie; Nicole A McGrath; Cecilia Monge Bonilla; Jianyang Fu
Journal:  J Gastroenterol       Date:  2020-08-03       Impact factor: 7.527

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.